Sensus Healthcare, Inc. (SRTS) Tops Q4 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Sensus Healthcare (SRTS) PT Raised to $9 at Maxim Group
February 2, 2018 7:36 AM ESTMaxim Group raised its price target on Sensus Healthcare (NASDAQ: SRTS) to $9.00 (from $7.50) while maintaining a Buy rating.
Analyst Anthony Vendetti cited Better-than-Expected 4Q17 Results and 510(k) Submissions for Two New Products.
... More